John Paulson’s Paulson & Co. disclosed in an SEC filing its holdings as of December 31, 2025. The fund’s one new buy during the fourth quarter was Solstice Advanced Materials (SOLS). Paulson exited two positions during the quarter, including by size of previous position, Honeywell (HON) and Trilogy Metals (TMQ). The fund increased its stake in two holdings, namely Bausch Health (BHC) and Thryv (THRY) and reduced its stake in one holding, namely Madrigal Pharma (MDGL). Paulson’s top holdings as of December 31, in order of size, were Madrigal, Perpetua Resources (PPTA), Bausch Health, Acadian Asset Management (AAMI), and Novagold Resources (NG).
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SOLS:
- Solstice Advanced Materials Balances Margin Pain With Growth
- Solstice Advanced Materials price target raised to $80 from $65 at Mizuho
- Solstice Advanced Materials price target raised to $87 from $75 at UBS
- Solstice Advanced Materials price target raised to $90 from $72 at BMO Capital
- Solstice Advanced Materials price target raised to $65 from $54 at Mizuho